Evidence map›Paper›PMID 40399622›Full record

ArticleCommunications biology2025

Negative cooperativity regulates ligand activation of DIAPH1 and other diaphanous related formins.

G G Theophall, A Premo, S Reverdatto, E Omojowolo, P Nazarian, D S Burz, R Ramasamy, A M Schmidt, A Shekhtman

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

G G TheophallDepartment of Chemistry, State University of New York at Albany, Albany, NY, USA.
A PremoDepartment of Chemistry, State University of New York at Albany, Albany, NY, USA.
S ReverdattoDepartment of Chemistry, State University of New York at Albany, Albany, NY, USA.
E OmojowoloDepartment of Chemistry, State University of New York at Albany, Albany, NY, USA.
P NazarianDepartment of Chemistry, State University of New York at Albany, Albany, NY, USA.
D S BurzDepartment of Chemistry, State University of New York at Albany, Albany, NY, USA.
R RamasamyDiabetes Research Program, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-9502-8265
A M SchmidtDiabetes Research Program, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-8902-070X
A ShekhtmanDepartment of Chemistry, State University of New York at Albany, Albany, NY, USA. ashekhtman@albany.edu.ORCID http://orcid.org/0000-0003-2649-2675

Funding

Project 3: RAGE/DIAPH1 interactions and cellular stressP01HL146367 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SHEKHTMAN, ALEXANDER · 2019 to 2023
$12.5M
Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic ComplicationsR01DK122456 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RAMASAMY, RAVICHANDRAN, SCHMIDT, ANN MARIE · 2020 to 2024
$3.1M
Real Time (RT) In-cell NMR technology to study protein interactions in live cellsR01GM085006 · NIGMS · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI SHEKHTMAN, ALEXANDER · 2010 to 2021
$2.4M
Chemical Modifications to Wobble Uridines in tRNA Regulate Responses to StressR01GM143749 · NIGMS · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI BEGLEY, THOMAS J, SHENG, JIA · 2022 to 2025
$1.4M
Zeiss LSM 980 Confocal Microscope SystemS10OD028600 · OD · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI VALM, ALEX M · 2022 to 2022
$477k
NHLBI NIH HHS P01 HL146367NIDDK NIH HHS R01 DK122456NIGMS NIH HHS R01 GM085006NIGMS NIH HHS R01 GM143749NIH HHS S10 OD028600U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) 1P01HL146367U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) 5R01DK122456U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) 5R01GM143749
6 · The paper itself

Abstract

DIAPH1 is a member of the family of Diaphanous Related Formins (DRFs) implicated in cell migration and cytokinesis. DRFs are maintained in an autoinhibited state by the intramolecular association between diaphanous inhibitory (DID) and diaphanous autoregulatory (DAD) domains. Actin polymerization requires the binding of activated RhoA to the GTPase binding domain (GBD) of DIAPH1 and the dissociation of DAD. In the presence of excess RhoA, actin polymerization is only partially activated. Using monomeric domain constructs of DIAPH1, the sequential binding affinities of RhoA and DAD to GBD-DID were characterized. Binding of RhoA and DAD were negatively cooperative requiring a 100-fold greater concentration of DAD to achieve saturation when RhoA binding site was occupied. The unimolecular architecture of full length DIAPH1 establishes an effective concentration of DAD in the micromolar range, which is 100-fold larger than the intrinsic affinity of DAD for DID. The effective concentration is large enough to maintain DIAPH1 autoinhibition, yet small enough to permit partial activation of DIAPH1 after RhoA binding. By exploiting negative cooperativity, DIAPH1 maintains a reserve of inactivated molecules enabling gradual responses to cellular processes that require prolonged and sustained regulation. The proposed mechanism is extended to other DIAPH1 activating ligands and broadly applicable to all DRFs.

Indexed as

Adaptor Proteins, Signal TransducingForminsrhoA GTP-Binding ProteinActinsBinding SitesHumansLigandsProtein BindingActinsAdaptor Proteins, Signal TransducingDIAPH1 protein, humanForminsLigandsrhoA GTP-Binding ProteinRHOA protein, human

Identifiers

PMID40399622
PMCPMC12095592

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.